Peter C. Adamson was named global development therapeutic area head of oncology and pediatric innovation at Sanofi. Based in Cambridge, MA, Adamson will lead the global development in cancer, and will work with leaders across therapeutic areas to further pediatric drug development efforts.
Vassiliki Papadimitrakopoulou was named clinical development leader of Pfizer Oncology and will join Pfizer Sept. 23.
The Cancer Prevention and Research Institute of Texas has awarded new grants totaling over $56 million and consisting of 13 academic research recruitment awards and a product development research award.
The National Comprehensive Cancer Network and the NCCN Foundation announced five new recipients for the 10th annual NCCN Foundation Young Investigator Awards Program.
G. David Roodman, an Indiana University Melvin and Bren Simon Comprehensive Cancer Center researcher, received a five-year, $1.6 million grant from the National Cancer Institute to study ways to build bone and decrease tumor growth in multiple myeloma bone disease.
MD Anderson Cancer Center and Innovent Biologics Inc. signed an agreement to co-develop TYVYT (sintilimab injection), Innovent's anti-PD-1 monoclonal antibody, in rare cancers in the U.S.
Five studies from the virtual scientific program of the 2020 American Society of Clinical Oncology Annual Meeting were highlighted in a press briefing and released May 13:
Three leaders were appointed to Roswell Park Comprehensive Cancer Center:xxx:moreMary Ann Long was named senior vice president of nursing. Long will focus on evaluating s
Science Health Education Center at Dana-Farber Cancer Institute launched the SHE Biobank initiative, a large, long-term study that will investigate the impact of genetic predisposition and environmental exposure to the development of disease
Sophie Paczesny and Shikhar Mehrotra were named co-leaders of the cancer immunology program at Hollings Cancer Center at the Medical University of South Carolina.
